BioPreventiveMedicine’s DNlite-IVD103 has approved by SFDA

撰文GlobalBio & Investment
日期2023-12-31
EnglishFrenchGermanItalianPortugueseRussianSpanish
BioPreventiveMedicine’s DNlite-IVD103 has approved by SFDA
“An ounce of prevention is worth a pound of cure”. Let’s give a round of applause to #BioPreventiveMedicine’s DNlite-IVD103! This state-of-the-art test is capable of predicting #kidney function decline in people with type 2 #diabetes and monitoring the progress of kidney transplant. The Saudi Food and Drug Agency (#SFDA) has approved this innovative assay and we have heard rumors that distributors are already showing interest.

Stay up-to-date with #globalbio for the latest news and click here for more insights.
https://lnkd.in/gPGxKsbS

#AKI #KidneyInjury
bio preventive medicine